UNSPSC 51352304: Estrofurate

This classification denotes a steroidal estrogen with the molecular formula C24H26O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 0CDE7T54KW, chemically known as 21,23-epoxy-19,24-dinor-17alpha-chola-1,3,5(10),7,20,22-hexaene-3,17-diol 3-acetate but generally known as estrofurate, which bears US NIH Compound Identifier 66360. European Medicines Agency schedules Estrofurate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07250MIG.

UNSPSC 51352304 Estrofurate is a Commodity code covering pharmaceutical products in state and local government procurement. The actual buying activity under this code centers on generic multi-source pharmaceuticals and over-the-counter products distributed through authorized wholesalers to state and local government facilities. State purchasing consortiums and departments of administration issue solicitations under this code, with multistate cooperative purchasing alliances serving as the primary vehicles for aggregating demand and establishing framework contracts that participating jurisdictions access for ongoing supply.

The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration's Office of State Procurement, issued an RFP on January 20, 2026 (due March 26, 2026) for generic multi-source pharmaceuticals and OTC products to be distributed across participating state and local government facilities in Minnesota, Oregon, and other MMCAP member jurisdictions. The solicitation requires vendors to supply products identified by National Drug Code, with pricing submission through three authorized wholesalers—AmerisourceBergen Drug Corporation (Cencora), Cardinal Health 110 and 112, and Morris & Dickson Co., LLC—and evaluation weighted 75 percent on price competitiveness, with secondary weight on administrative compliance, EDI capability, and fixed pricing. Awarded vendors must maintain cGMP and DSCSA compliance, hold contractual relationships with at least two of the three authorized wholesalers, carry insurance including $5 million in commercial general liability and $2 million in network security and privacy liability, and accept a 3 percent administrative fee on all purchases. The contract term runs two years for new responders with optional extensions, while incumbent responders' amendments extend through June 30, 2028.